Lixte Biotechnology Holdings Inc. (LIXT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hurley Capital Charles Goldblum | 631 | $2,477 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.51 | 5,527 | $13,872.77 | 25,000 | 2023-10-03 | Filing | |
| $2.29 | 4,473 | $10,243.17 | 19,473 | 2023-10-02 | Filing | |
| $2.80 | 10,000 | $28,000.00 | 11,000 | 2023-10-03 | Filing | |
| $2.51 | 5,527 | $13,872.77 | 0 | 2023-10-03 | Filing | |
| $2.29 | 4,473 | $10,243.17 | 0 | 2023-10-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 153,860 | $603,900 | 0% | |
| 2. | 10,613 | $41,656 | 0% | |
| 3. | 7,810 | $30,654 | 0% | |
| 4. | 190 | $746 | 0% | |
| 5. | 141 | $553 | 0% |
Hedge Fund Resource Center